International Journal of Oncology Research is an open access, peer reviewed, multidisciplinary journal focused to publish articles on developments of all types of malignancies including pathology, diagnosis and therapy, including radiotherapy, and systemic treatment. Articles submitted to the journal will be subjected to standard peer review process to ensure the quality of submitted content.
The journal invites significant and up-to-date articles within the fields of experimental and clinical oncology. The articles on aspects covering apoptosis, biotherapeutics, bone marrow transplantation, cancer biology, cancer epidemiology, cancer etiology, cancer prevention, cancer rehabiliation medicine, cancer screening and diagnosis, cell differentiation & proliferation, chemotherapeutic agents, clinical imaging, cytogenetics, emerging therapeutics, flow cytometry, general hematology and oncology, medical oncology, molecular biology module, neoplasms, oncologic emergencies, oncology nursing, principals of endocrine therapy, principles of cancer pathology, psyco oncology, radiation oncology, societal oncology, surgical oncology, transfusion medicine, tumor immunology, etc.
Articles Search by Keyword | Journal title | Author name | DOI
Open Access DOI:10.23937/ijor-2017/1710009
Fadi Nasr, Ahmad Al Ghoche, Saada Diab, Janah Maddah, Layal Mansour, Ali kassem and Abd El Karim Gheith
Article Type: Case Report | First Published: November 12, 2018
Despite of the high incidence of hepatocellular carcinoma (HCC), treatment strategies stays restrained. New treatment aspects remain a necessity to improve overall survival of patients. Here, we report for the first time a 2 years complete remission of hepatocellular carcinoma with pembrolizumab after failure of sorafenib and progression after liver transplantation. Immunotherapy became a field of interest in HCC for researchers and clinicians in order to establish new immunotherapy modalities t...
Open Access DOI:10.23937/IJOR-2017/1710008
Andrew Octavian Sasmita and Ying Pei Wong
Article Type: Review Article | First Published: October 06, 2018
Having been identified for centuries, breast cancer still remains one of the leading causes of death in women. Within the United States of America (USA) alone, it is estimated that over 60,000 women would have developed new cases of malignant breast cancer in 2017 alone; thus, calling an attention for the development of a reliable and effective breast cancer model for drug discovery to combat the disease or diagnostics to predict the progression ...
Open Access DOI:10.23937/IJOR-2017/1710007
Shaoyu Fan, Zhengzhong Mao, Anita H Lee and Teh-wei Hu
Article Type: Case Report | First Published: September 29, 2018
The estimated total national medical cost of treating lung cancer patients in China was 64.21 billion RMB (US$ 10.31 billion), about 2% of total medical costs in 2015. Total lung cancer costs in 2015 were 488.53 billion RMB (US$ 78.42 billion), about 75% of which can be attributed to mortality costs. Two-thirds of the lung cancer patients in the sample were either current or former smokers. The major economic costs of lung cancer among smokers are preventable. China has a relatively low cigarett...
Open Access DOI:10.23937/ijor-2017/1710006
Ashraf Farrag, Arif Shaukat, Muhammad Ali and Magdy Kandil
Article Type: Research Article | First Published: July 28, 2018
Oral cancer is the most common head and neck cancer (HNC). Its global incidence in 2015 was 410,000 cases with 146,000 deaths. In USA, 41,380 patients were diagnosed with HNC in 2013, and oral cavity cancers accounted for almost 30,000 of new cases. In Saudi Arabia, a total number of 211 oral cancer cases were reported in 2014, representing about 1.8% of the total cancer cases....
Open Access DOI:10.23937/ijor-2017/1710005
J Bisnath, R Ramkissoon and J Ali
Article Type: Case Report | First Published: June 11, 2018
Treatment of Stage Four Breast Cancer has traditionally excluded locoregional surgery, with the focus being on control of the distant disease. Much of what is applied in clinical practice is extrapolated from chemotherapy trials in the adjuvant setting, with taxanes and anthracyclines incorporated early on in the treatment course....
Open Access DOI:10.23937/ijor-2017/1710004
Yoshiomi Hatayama, Masahiko Aoki, Hideo Kawaguchi, Katsumi Hirose, Mariko Sato, Ichitaro Fujioka, Mitsuki Tanaka, Koji Ichise, Shuichi Ono and Yoshihiro Takai
Article Type: Original Article | First Published: March 31, 2018
Fifteen patients with locally advanced stage III pancreatic cancer underwent radiotherapy with or without concurrent chemotherapy between July 2006 and April 2014. We used 10 MV X-rays and multiple coplanar (two to four) fields. The number of fractions ranged between 20 and 28 with a fraction size of 1.8Gy. A total dose of 36-50.4Gy at the isocenter of the planning target volume (PTV) was administered to each patient. Fourteen patients received c...
Open Access DOI:10.23937/ijor-2017/1710003
Kazutaka Otsuji, Takeshi Sasaki, Keiichiro Tada, Masashi Fukayama and Yasuyuki Seto
Article Type: Original Article | First Published: February 26, 2018
A new immunohistochemistry (IHC) method using fluorescence-emitting phosphor-integrated dot (PID) nanoparticles as a fluorescent dye was developed to accurately detect proteins that are expressed by cancer cells. This technique localizes proteins and quantitates their levels of expression in cancer lesions, which facilitates objective analysis of protein levels. We used the PID nanoparticle assay to measure HER2 expression in formalin-fixed, para...
Open Access DOI:10.23937/ijor-2017/1710002
Joseph Brandt, Jack Morgani, Alan Heimann and Edna Kapenhas
Article Type: Case Report | First Published: November 16, 2017
Since first being noted in the literature in 1966, Secretory Breast Carcinoma (SBC) continues to be better defined in terms of its clinical, histologic, and genetic features. However, its unique presentation can elude seasoned practitioners from making a clinical diagnosis....
Open Access DOI:10.23937/ijor-2017/1710001
Yasuhiro Nakmaura and Uch Somary
Article Type: Review Article | First Published: November 01, 2017
Cambodia is considered to be endemic to chronic gastritis due to Helicobacter pylori (HP). Prevalence of HP is more than 70% inferred from the literature of neighboring countries. However, Cambodia, being a developing nation, doesn’t have enough resources for the screening of HP. On the other hand, after the Kyoto Global Consensus in 2015, risk evaluation of gastric carcinoma based on endoscopic findings with image-enhanced modalities and magni...
ClinMed International Library
All articles are fully peer reviewed, free to access and can be downloaded from our ClinMed archive.
Contact our editorial office